The global Vibrio diagnostics market is prophesied in a report by Transparency Market Research (TMR) to testify an upsurge in its growth due to certain factors such as improved healthcare spending, increasing awareness, and introduction of rapid diagnostics tests. Titled “Vibrio Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the report foresees the market to be classified according to end user and diagnostic technique segmentation categories. Private and commercial diagnostics laboratories, hospitals, and public health laboratories could be primary end users of Vibrio diagnostics. Improving healthcare facilities and increasing awareness have been prognosticated to expand the share of hospitals in the market.
In terms of diagnostic technique, the world Vibrio diagnostics market is expected to be classified into immunoprecipitation, fluorescent immunoassays, immuno-polymerase chain reaction (immuno-PCR), diagnostic imaging, monoclonal antibodies, flow cytometry, polymerase chain reaction (PCR), and enzyme immunoassays (EIA). Rising research and development in Canada and the U.S. and technological advancement could help PCR to rank higher in the market. According to region, Asia Pacific could hold a leading share of the market while riding on crucial growth factors such as the need for change taking into consideration unhygienic living conditions, unsafe drinking water, and poor sanitation.
Diseases such as cholera caused due to bacterium Vibrio cholerae is more common in the Middle East and Africa and Southeast Asia countries, as per a report by the Centers for Disease Control and Prevention (CDC). However, it is uncommon in developed countries such as the U.S. The overall market for Vibrio diagnostics has been expected to see a rise in the near future owing to other important factors such as the affordability of diagnostics devices and kits and quick outcome. Moreover, the evolution of cutting-edge diagnostics techniques such as EIA and PCR could set the tone for a significant growth of the world Vibrio diagnostics market.
Regions experiencing the rise of global warming could be breeding grounds for Vibrio species, thus increasing the demand for accurate and effective diagnostics techniques to combat the associated diseases in advance. The intake of raw and uncooked foods in rural areas and increasing peri-urban slums have been projected to create opportunities in the international Vibrio diagnostics market. Vibrio bacteria are generally found in temperate and subtropical waters, although some of them could also be located in a freshwater environment. A deeper research about these species has found out that they could be present in marine and estuarine environments as well.
The U.S. witnesses hundreds of hospitalizations and deaths every year because of diseases caused due to dozens of bacterial species. Septicemia and wound infections are some of the typical seafood-borne diseases lead by various types of Vibrio species. Inappropriate management of environments and rising fatality rates due to cholera in Asia and Africa have been forecast to offer scores of prospects in the international Vibrio diagnostics market. New strains of Vibrio bacteria have already been found in these continents, which could mean that there may be a continuous need for Vibrio diagnostics in the coming years.
The worldwide Vibrio diagnostics market has been expected to witness the presence of some of the top-ranking players of the industry such as Fujirebio Diagnostics Inc., Eiken Chemical Co. Ltd., Diamedix Impex S.A., Becton, Dickinson and Company, and Abbott Laboratories. The analysts authoring the report have comprehensively profiled important companies operating in the market.
Request to View Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2271